09 Feb 2023 Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease Member news
08 Feb 2023 Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure Member news
07 Feb 2023 Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture Member news
02 Feb 2023 Mithra CDMO announces collaboration with VaRi Bioscience for the development of a long-acting product in women’s health Member news
24 Jan 2023 AcademicLabs partners with BioRN Community to identify regional collaborators and boost visibility Member news
24 Jan 2023 Connected-Pathology invests in novel Milestone automation processing instruments, simultaneously becoming Milestone’s prototype testing partner Member news
23 Jan 2023 Connected-Pathology and KU Leuven Institute for Single Cell OMICS (LISCO) announce a partnership to offer multiplex immunohistochemistry services Member news
18 Jan 2023 Annals of the Rheumatic Diseases publishes results from two bimekizumab Phase 3 studies in axial spondyloarthritis Member news
20 Dec 2022 Richter and Mithra sign binding Heads of Terms for commercialization of Donesta® Member news
16 Dec 2022 Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
